After acquiring local oncology firm, MorphoSys plans to grow in Boston

When MorphoSys AG acquired oncology firm Constellation Pharmaceuticals Inc. for $1.7 billion, it instantly doubled its Boston-area headcount — and according to CEO Jean-Paul Kress, the company has no plans to slow down local growth.